Drug Shortage Report for SANDOZ OLANZAPINE ODT

Last updated on 2021-01-12 History
Report ID 130134
Drug Identification Number 02327775
Brand name SANDOZ OLANZAPINE ODT
Common or Proper name SANDOZ OLANZAPINE ODT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30 UDCA
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-12-11
Estimated end date 2021-01-08
Actual end date 2021-01-08
Shortage status Resolved
Updated date 2021-01-12
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-12-14 English Compare
v2 2020-12-14 French Compare
v3 2021-01-12 English Compare
v4 2021-01-12 French Compare